Local Tranexamic Acid in Facelift Surgery Is Not Associated With Wound Healing Complications: A Matched, Single-Surgeon Cohort Study
Aesthetic Surgery Journal · 17.11.2025 · 45 (12) · 1213-1219
DOI: 10.1093/asj/sjaf130 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 04.07.2025. Verfasst von Osama Darras und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tranexamic Acid, Wound Healing, Rhytidoplasty, Antifibrinolytic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Recent anecdotal reports from respected surgeons suggest a potential link between tranexamic acid (TXA) in local anesthetic solutions and wound healing complications during facelift procedures.
Objectives
The authors of this study evaluate outcomes in patients undergoing facelift with and without local TXA injection.
Methods
A single-surgeon retrospective cohort study was conducted on patients who underwent facelift surgery under general anesthesia between 2014 and 2024. All received subcutaneous injections of 0.5% lidocaine with 1:200,000 epinephrine, with or without TXA. Patients were matched for age, BMI, sex, and hypertension. Operative time and postoperative complications were assessed.
Results
Each group had 261 patients with a median follow-up of 232 days. No significant differences were observed in age (P = .22), BMI (P = .59), sex (P = 1.00), hypertension (P = .52), primary vs secondary facelifts (P = .19), fat grafting (P = .66), or chemical peels (P = .83). Minor wound healing complications were similar (P = .16). Delayed healing occurred in 4.6% (non-TXA) vs 2.3% (TXA) (P = .15). Minor skin necrosis was noted in 1 non-TXA patient (0.4%) and 2 TXA patients (0.8%) (P = 1.00). Two major complications, major skin necrosis, were reported in the non-TXA group, none in TXA (P = .5). Hematoma rates were comparable (P = 1.00).
Conclusions
The authors of this large-scale, single-surgeon, retrospective cohort study of matched patients challenge previous claims associating TXA use with wound healing complications. Local administration of TXA in a concentration of 1 to 2 mg/mL is not associated with an increased risk for minor or major wound healing complications in patients undergoing facelift procedures with wide skin undermining. TXA appears safe when used with appropriate dosing, screening, and technique. Level of Evidence : 3 (Therapeutic)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Osama Darras
Zitieren
APA
Darras, O., Janssen, P. L., Fraiman, E., Reategui, A., & Zins, J. E. (2025). Local Tranexamic Acid in Facelift Surgery Is Not Associated With Wound Healing Complications: A Matched, Single-Surgeon Cohort Study. Aesthetic Surgery Journal, 45(12), 1213-1219. https://doi.org/10.1093/asj/sjaf130
Vancouver
Darras O, Janssen PL, Fraiman E, Reategui A, Zins JE. Local Tranexamic Acid in Facelift Surgery Is Not Associated With Wound Healing Complications: A Matched, Single-Surgeon Cohort Study. Aesthetic Surgery Journal. 2025;45(12):1213-1219. doi:10.1093/asj/sjaf130
BibTeX
@article{Darras2025,
author = {Darras, Osama and Janssen, Pierce L and Fraiman, Elad and Reategui, Alvaro and Zins, James E},
title = {Local Tranexamic Acid in Facelift Surgery Is Not Associated With Wound Healing Complications: A Matched, Single-Surgeon Cohort Study},
journal = {Aesthetic Surgery Journal},
year = {2025},
volume = {45},
number = {12},
pages = {1213--1219},
doi = {10.1093/asj/sjaf130}
}
EUVIMED